Clinical Trials Browser

Lymphoma, Follicular × Brentuximab Vedotin × 1 year × Clear all

NCT04587687 2025-04-24

Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

Phase 2 Recruiting

Lymphoma, Follicular